| 2024 | Invited Plenary Talk | Chilean Infectious Diseases Society Annual Meeting |
| 2024 – Present | Vice Chair | ACTG HIV Reservoirs and Viral Eradication Transformative Science Group (Cure TSG) |
| 2024 | Award | BWH Department of Medicine Research Excellence Award |
| 2024 | Invited Lecture | UT Southwestern Infectious Disease Grand Rounds |
| 2024 – Present | Member | IDSA COVID-19 Treatment Guidelines Panel |
| 2024 | Session Chair | Conference on Retroviruses and Opportunistic Infections (CROI) |
| 2024 | Invited Lecture | 14th Portuguese Conference on Infectious Diseases |
| 2023 – Present | Director | ACTG Virology Core Laboratories |
| 2023 – Present | Steering Committee Member | Massachusetts Consortium on Pathogen Readiness |
| 2023 | Session Chair | ID Week 2023 |
| 2023 | Invited Keynote Talk | Melbourne HIV Exchange Would AIDS Day Symposium, Melbourne, Australia |
| 2023 | Invited Lecture | University of Pennsylvania HIV Grand Rounds |
| 2023 | Invited Lecture | Conference on Retroviruses and Opportunistic Infections (CROI) |
| 2023 | Invited Lecture | HIV Cure Symposium, Ghent, Belgium |
| 2023 – Present | Protocol Virologist | ACTG studies A5419, A5420, A5425 |
| 2022- Present | Director | BWH ID Fellowship Research Director |
| 2022- Present | Deputy Editor | Journal of Infectious Diseases |
| 2022 | Elected Member | American Society for Clinical Investigation |
| 2022 | Tim Gill Distinguished Lecturer | University of Colorado |
| 2022 | Session moderator | ID Week 2022 |
| 2021 – 2024 | Member | NIH COVID-19 Treatment Guidelines Panel |
| 2020 | Top 50 Most Downloaded SARS-CoV-2 Papers in 2020 | Nature Communications |
| 2020 – Present | Director | Harvard Center for AIDS Research Clinical Core |
| 2019 – 2022 | Representative | ACTG Executive Committee |
| 2019 | Top 10% Most Downloaded Paper over the Past 2 Years | Journal of Infectious Diseases |
| 2018 – Present | Deputy Editor | Open Forum Infectious Diseases |
| 2018 | Associate Director | Harvard Center for AIDS Research Clinical Core |
| 2018 | Most Cited Basic Science Paper of 2018 | AIDS |
| 2017 – Present | Director | Harvard Virology Specialty Laboratory of the ACTG |
| 2015 – Present | Co-Chair | ACTG Trials A5345 and A5347 |
| 2015 | HIV Research Scholar | Gilead Sciences |
| 2015 | Fellow | Infectious Disease Society of America |
| 2014 – 2018 | Associate Editor | Open Forum Infectious Diseases |
| 2014 – Present | Co-Chair | ACTG Trial A5308 |
| 2014 | Co-Chair | ACTG Analytic Treatment Interruption Working Group |
| 2014 | John Carey Young Investigator Award | AIDS Clinical Trials Group (ACTG) |
| 2013 | Editorial Advisory Board | Journal of Infectious Diseases |
| 2012 | Maxwell Finland Award for Research Excellence | Massachusetts Infectious Disease Society |
| 2012 | Conference Scholarship | International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies |
| 2012 | Young Investigator Award | 19th Conference on Retroviruses and Opportunistic Infections (CROI) |
| 2011 | Conference Scholarship | International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies |
| 2011 | Young Investigator Award | 18th Conference on Retroviruses and Opportunistic Infections (CROI) |
| 2010 | Young Investigator Award | 17th Conference on Retroviruses and Opportunistic Infections (CROI) |
| 2009 | Edward H. Kass Award for Clinical Excellence | Massachusetts Infectious Disease Society |
| 2007 | Jeffrey Weingarten Award for Housestaff | University of California, San Francisco |
| 2006 | Teaching Excellence Award for Cherished Housestaff | University of California, San Francisco |
| 2006 | Floyd C. Rector Research Symposium Award | University of California, San Francisco |
